Spotlight on IGCS Fellows & Mentors

The IGCS Member Spotlight is back, now with a focus on Fellows and International Mentors participating in the IGCS Global Curriculum & Mentorship Program.

Ricardina Rangeiro
Hospital Central de Maputo
Maputo, Mozambique
Fellow of the IGCS Global Curriculum & Mentorship Program

Where did you complete your training? Or tell us about your background in gyn oncology.
I’m doing my training in Mozambique that I started in 2018. 

Why did you decide to pursue a career in gyn oncology or what about it interested you?  
I’ve always been interested in oncology and during my residency, I’ve noticed that the patients arrived in advanced stages, so I thought what could I do to make a change. 

Tell us about your work in women’s cancer: daily activities and/or special projects.
I work in a ward that take care of women with gynecological cancer. Every day we do rounds, stage the patients with cancer, do biopsies. We also do colposcopies and leeps in the clinic of pre-invasive lesions. Twice a week we do surgeries. 

Tell us about the person or people who have inspired you the most in your career.
My mother, she is a pediatrician and the person responsible for my love of medicine.  

What is the most rewarding part of your career?
The most rewarding part of my career is being capable to treat and relieve the pain of our patients and being able to help these women. 

What is the most beneficial resource or equipment you have access to at your training site?
The most beneficial resource or equipment we have access to is the big volume of patients and radiotherapy. 

What is one of the biggest challenges in gyn cancer care in your region? What resources are lacking?
One of the biggest challenges in gyn cancer care in my region is that there isn’t enough trained medical staff. There is only 1 radiotherapy center for the entire country, and the pathology center with the best trained pathologists is only available in Maputo. 

How long have you been a member and how did you become involved with IGCS?
I’ve known IGCS when I started the program. 

Is there a story/example of a time you were especially proud of your involvement with IGCS?
I’m always proud of my involvement with IGCS. It’s been such an honor to be part of this program and being able to make a huge change in cancer care of gynecology patients. 

What does being a part of the IGCS Global Curriculum & Mentorship Program mean to you?
Being part of the IGCS Global Curriculum & Mentorship Program means I’m being trained by the best in this area, which is a unique experienceIt means a lot to have access to mentors and their guidance because we can get the tools we need to treat thpatients 

Do you have any hobbies or is there an interesting fact about your life that you’d like to share?
Apart from medicine, I like to run. It’s my moment, only mine, to recharge my battery. And of course, enjoy quality time with family and friends. 

What is a unique or fun fact about your country or community culture?
We are a resilient people; against all odds, we get up every day and get the job done with a smile on our faces 

Does your country/region have a traditional food or drink? Do you like it?
Yes, our prawns are one of the best in the worldZambezian chicken prepared with coconut milk, our matava and drinks we have maheu that is made with corn flour are also good. 

 

See more Member Spotlights.

Would you like to be featured in the Member Spotlight? We’d love to hear your story! Complete this form.

Fellows and Mentors in the IGCS Global Curriculum & Mentorship Program should complete this form which includes additional prompts about the program.

CEO Update: COVID-19 Survey Results

Dear Members and Friends,

In this CEO Update, I’d like to share with you the results from our recent COVID-19 survey, provide an update on IGCS 2020 abstracts and our upcoming Surgical Film Festival with AAGL, and remind readers of the International Journal of Gynecological Cancer to complete the 2020 readership survey.

COVID-19 Survey Results

We would like to thank our members for taking the time to complete our international survey of gynecologic cancer care providers to help us better understand the global impact of the COVID-19 pandemic on cancer care in the initial months of the pandemic. An executive summary of the results is now available.

Download COVID-19 Survey Results Executive Summary

We received responses from a total of 270 participants from 62 countries, with representation largely from North America, South America, and Asia. 83% were gynecologic oncologists and the rest included medical oncologists, radiation oncologists, pathologists, and nurses. The primary practice of 97% of participants is in clinical work and 91% work in an urban setting. 70% work in academic medical centers while 26% work in community hospitals.

From the survey responses, we learned that there is a definite and urgent need for the IGCS to comprehensively evaluate and understand the impact of the COVID-19 pandemic on gynecologic cancer practice and women’s cancer care. This understanding goes to the raison d’être of the Society in supporting its membership through education, advocacy, and political activism for women living with cancer all over the world. If you are interested in informational resources IGCS has compiled related to cancer care and COVID-19, please visit our COVID-19 page for resources, articles and recordings of educational tumor boards.

I would also like to thank Dr. Joseph Ng, IGCS Council Member and Chair of the Mentorship and Training Committee for his work in developing the survey questions and Dr. Li Min Lim for analyzing and compiling the executive summary.

The IGCS will be diving deeper and into some of the comments and responses you have provided. We intend to share what we find on these deep dives across our entire suite of information-distribution platforms including social media and in our society journal, the International Journal of Gynecological Cancer.

IGCS 2020 xDigital Annual Global Meeting

Abstract and Surgical Film Submission for the IGCS 2020 Annual Global Meeting closed on July 15, 2020 at 11:59 pm PDT. We are grateful to have received over 500 abstracts and surgical films.

Late Breaking Abstracts will be accepted from July 25-August 15. Please note that the late breaking submission site is reserved for high priority data that was not fully available at the time of original submission deadline on July 15. Other submissions will not be considered for acceptance.

There is still plenty of time to register for IGCS 2020. Learn more about the meeting which will be 100% digital. Session details will be released soon but until then, please view the program overview to see all the great sessions that will be offered.

IGCS/AAGL Surgical Film Festival

The next IGCS/AAGL Film Festival covering surgical complications will be held July 29, 2020 at 5:00 pm CDT. This online event is free but registration is required. View the program outline and speakers.

 

IJGC Readership Survey (July 2020)

The International Journal of Gynecological Cancer is conducting a readership survey to collect feedback from IGCS members and subscribers regarding journal content and educational offerings such as podcasts, video articles and different article types.

Please complete the IJGC survey here.

 

In closing, I’d like to thank the numerous volunteer leaders who allow IGCS to achieve our goals and better the care for women with gynecologic malignancies.

Sincerely,

Mary Eiken, MS
IGCS CEO

IGCS-AAGL Surgical Film Festival

IGCS in partnership with AAGL is providing a free online surgical film festival narrated by expert surgeons in the field of gynecologic oncology. Attendees can participate in live discussion while viewing the surgical films.

State-of-the-Art Surgical Film Festival: Complications
Wednesday, July 29, 2020

5:00 pm – 7:00 pm CDT

Ureteral & Bladder Complications (AAGL)
Bladder Injury and Repair & Post-operative Management
60 minutes

Moderator

Dr. Suketu Mansuria
University of Pittsburgh School of Medicine; Magee Women’s Hospital 
USA

 

Intra-Op Repair, Repair of Delayed Injury, and Post-operative Management

Dr. Ted Lee
University of Pittsburgh School of Medicine; Magee Women’s Hospital 
USA

 

Dr. Erin Carey
University of North Carolina
USA

Intra-Op Repair vs. Delayed Diagnoses, Reimplantation vs. Reanastamosis, Post-Op Management

Dr. Javier Magrina
Mayo Clinic
USA

 

Dr. Jim Robinson
MedStar Washington Hospital Center
USA

 

Bowel & Vascular Complications (IGCS)
60 minutes

Moderator

Dr. Vance Broach
Memorial Sloan-Kettering Cancer Center
USA

 

Vascular Injury & Repair, External Iliac Vessel

Dr. Mario Leitao
Memorial Sloan-Kettering Cancer Center
USA

 

Vascular Injury & Repair, Inferior Vena Cava

Dr. Jamie Bakkum Gamez
Mayo Clinic
USA

 

Managing Thermal Injury to Bowel

Dr. Jennifer Mueller
Memorial Sloan-Kettering Cancer Center
USA

 

Management of Anastomotic Leak

Dr. Bill Cliby
Mayo Clinic
USA

 

 

 

IGCS COVID-19 Survey Results

We would like to thank our members for taking the time to complete our international survey of gynecologic cancer care providers to help us better understand the global impact of the COVID-19 pandemic on cancer care in the initial months of the pandemic. An executive summary of the results is now available.

Download: IGCS Survey on the Impact of COVID-19 on Gynecologic Cancer Care Executive Summary July 2020

We received responses from a total of 270 participants from 62 countries, with representation largely from North America, South America, and Asia. 83% were gynecologic oncologists and the rest included medical oncologists, radiation oncologists, pathologists, and nurses. The primary practice of 97% of participants is in clinical work and 91% work in an urban setting. 70% work in academic medical centers while 26% work in community hospitals.

From the survey responses, we learned that there is a definite and urgent need for the IGCS to comprehensively evaluate and understand the impact of the COVID-19 pandemic on gynecologic cancer practice and women’s cancer care. This understanding goes to the raison d’être of the Society in supporting its membership through education, advocacy, and political activism for women living with cancer all over the world. If you are interested in informational resources IGCS has compiled related to cancer care and COVID-19, please visit our COVID-19 page for resources, articles and recordings of educational tumor boards.

I would also like to thank Dr. Joseph Ng, IGCS Council Member and Chair of the Mentorship and Training Committee for his work in developing the survey questions and Dr. Li Min Lim for analyzing and compiling the executive summary.

The IGCS will be diving deeper and into some of the comments and responses you have provided. We intend to share what we find on these deep dives across our entire suite of information-distribution platforms including social media and in our society journal, the International Journal of Gynecological Cancer.

Education Highlight: In the Know

This month’s Education Highlight is from In the Know (Ed’s List)

In the Know is prepared by Edward Pavlik, PhD, Professor and Director of Ovarian Screening Research Program, University of Kentucky on a monthly basis. Ed’s lists provide a compilation of abstracts related to the field of gynecologic oncology from multiple scholarly journals.

Here’s an example of one abstract from the June 2020 In the Know compilation:

Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: A prospective study of 239 women. MP Salcedo, AK Sood, A Jhingran, PJ Eifel, AH Klopp, RB Iyer, BM Fellman, C Jimenez, KM Schmeler. Cancer, (2020) 126: 2607-2613. doi:10.1002/cncr.32807 https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.32807

Background  Advances in radiotherapy (RT) have led to improved oncologic outcomes for women with gynecologic cancers; however, the long‐term effects and survivorship implications need further evaluation. The purpose of this study was to determine the incidence of pelvic fractures and changes in bone mineral density (BMD) after pelvic RT.

Methods  Two hundred thirty‐nine women who had pelvic RT for cervical, endometrial, or vaginal cancer between 2008 and 2015 were prospectively studied. BMD scans and biomarkers of bone turnover were obtained at the baseline and 3 months, 1 year, and 2 years after RT. Imaging studies were assessed for pelvic fractures for up to 5 years. Patients with osteopenia, osteoporosis, or pelvic fractures at any point were referred to the endocrinology service for evaluation and treatment.

Results  The median age at diagnosis was 51 years; 132 patients (56%) were menopausal. The primary diagnoses were cervical (63.6%), endometrial (30.5%), and vaginal cancer (5.9%). Sixteen patients (7.8%; 95% confidence interval, 4.5%‐12.4%) had pelvic fractures with actuarial rates of 3.6%, 12.7%, and 15.7% at 1, 2, and 3 years, respectively. Fractures were associated with baseline osteoporosis ( < .001), higher baseline bone‐specific alkaline phosphatase ( < .001), and older age ( = .007). The proportion of patients with osteopenia/osteoporosis increased from 50% at the baseline to 58%, 59%, and 70% at 3 months, 1 year, and 2 years, respectively.

Conclusions  A high proportion of women had significant decreases in BMD after pelvic RT, with 7.8% diagnosed with a pelvic fracture. BMD screening and pharmacologic intervention should be strongly considered for these high‐risk women.

Stay “In the Know” and keep up with Ed’s List in the Members-Only IGCS Literature Library. Click here to login to the Member’s Education Portal and access the entire archive.

Leading Together

President’s Perspective

IGCS Members and Friends,

We are all on a journey with COVID-19. All over the world, our way of life is changing, and priorities are shifting.

There is still so much to learn, behavior to change, data to gather and analyze, all while trying to reassemble our lives both personally and professionally within this new era marked by a virus. The last several months are unlike anything most of us have experienced in our lifetimes. The only certainty today is uncertainty – and this is going to take time, lots of time.

To undertake this journey, we must be multidimensional and adapt boldly to the changing circumstances. This includes being acutely self-aware, insatiably curious, authentic, resilient, flexible, and courageous. Now more than ever, the world needs strong leadership, decisive action, innovative ideas, and effective communication.

Many of you may find yourselves in leadership positions with your colleagues, divisions and departments, your friends and even your families. Priorities, responsibilities, and roles may have shifted dramatically in the past several months. Effective leaders are now more important than ever.

As an organization, the IGCS is no different. We have taken the lead in transforming our Annual Global Meeting to a fully digital meeting because we believe in the importance of sharing data and science, uniting the gynecologic cancer community, and continuing to focus on our patients in these times of uncertainty.

I am grateful to the IGCS Council for being my partners in leading the society through this trying time, making tough decisions, assessing risk, and moving forward swiftly and decisively. I must also acknowledge the IGCS staff who have been relentless in leading our efforts to transform IGCS not only from the Annual Meeting perspective but organizationally as well.

IGCS xDigital Annual Global Meeting
September 10-13, 2020

The IGCS xDigital Meeting will be held this September and I hope that you all will join us and experience our innovative new meeting portal. We have been quick to adapt our regular meeting format to accommodate the needs of our members and partners and we are excited to deliver a unique meeting experience with “xDigital” technology that is so much more than a webinar.

  • The program will feature multiple simultaneous sessions (or channels) and delegates can easily move from one session room to another.
  • The sessions are scheduled for different time zones each day to accommodate our global audience.
  • The main sessions are equipped with audience participation features such as live polls and Q&A.
  • Delegates will be able to connect and communicate with each other within the meeting portal.
  • A digital exhibition hall will be brought to life with 3D rendered spaces and delegates will be incentivized to visit all the exhibit booths where they can access videos and downloadable materials and schedule meetings with industry representatives.

Registration

One major benefit of this new format is that the cost of attendance is significantly lower than it would be to travel and attend a physical meeting and we hope that this will make the IGCS Meeting more accessible than ever for our members and friends around the world. In true IGCS fashion, we are collaborating with many regional groups to offer group registration packages as well.

Abstract and Surgical Film Submission

Abstracts and surgical films are being accepted through July 15 and late-breaking abstracts will be accepted from July 25-August 15.  Late-breaking abstracts should contain new information that was not available prior to the general deadline. Don’t miss your chance to lead the way and present at the first IGCS xDigital Meeting!

Now is the time to come together (digitally) to share our experiences, discuss lessons learned, and meet the challenges we face head-on. With our combined expertise, creativity, and compassion, we will lead together through these trying times. We are making plans for IGCS to gather in Rome in 2021 and I truly hope to see you all there face-to-face but until then help us lead IGCS into a new era, new way of conducting education and disseminating vital knowledge.

Sincerely,

Roberto Angioli, MD
2018-2020 IGCS President

Patient Perspectives Roundtable

Virtual Patient Perspectives Roundtable
Patient Advocacy & Support in the Backdrop of COVID-19

Tuesday, June 30, 2020
View the recording of the session below.


Presenting Organizations:

[/su_row

This Virtual Roundtable—focused on gynecologic cancer patient advocacy and support—is an online version of the IGCS Patient Perspectives Roundtable Series. It is structured to adhere to the safety guidelines in place during the COVID-19 pandemic while addressing information gaps and needs and continuing the exchange of essential information in this constantly evolving environment.

Moderator

Maurício Magalhães Costa
Member, IGCS Council
Member, National Academy of Medicine
President, Senologic International Society
Coordinator, Breast Unit of Americas Center of Oncology
Brazil

Panelists

Endometrial Cancer Action Network for African-Americans (ECANA)

Kemi M. Doll
Project Lead, ECANA
Gynecologic Oncologist
University of Washington
USA

Margie Willis
Advocate, ECANA
Endometrial Cancer Survivor
USA

SHARE Cancer Support (Breast, Ovarian, and Uterine)

Kitty Silverman
Uterine Cancer Program Coordinator, SHARE
USA

Nefa-Tari Moore
Uterine Cancer Program Associate/Helpline Coordinator/Support Group Facilitator, SHARE
Ovarian & Uterine Cancer Survivor
USA

Women4Cancer Early Detection & Treatment

Benda Kithaka
Co-Founder/Chair, Women4Cancer Early Detection & Treatment
Kenya

 

 

About the IGCS Patient Perspectives Roundtable Series
During the COVID-19 pandemic and in its aftermath, IGCS will continue to be a global source of education and resources, training, public awareness, and advocacy. Virtual Roundtables will

  • facilitate first-hand assessment of patient community needs and concerns
  • provide vetted information, assessments, and guidance from key opinion leaders and seasoned survivors/advocates
  • address current patient and wider community concerns through live responses to question posted online during the session
  • promote strategic conversations with health care and research communities around specific issues
  • assist all in coming to workable solutions and strategies for moving forward during the COVID-19 pandemic and in its aftermath

Each 60- to 90-minute session will cover a specific topic important to the gynecologic cancer patient communities maneuvering through the health and cancer care system during and after COVID-19 and will include IGCS key opinion leaders, patients-caregivers, and other stakeholders appropriate to the topic.

Previous Virtual Roundtable
Patient Care & Clinical Trials in the Midst of COVID-19
May 23, 2020
This event was supported by a grant from the GOG Foundation, Inc.
Upcoming Virtual Roundtable
More information on future roundtables is coming soon.

Welcome, SASGO!

We are so pleased to announce that the South African Society of Gynaecologic Oncology (SASGO) has joined the IGCS Strategic Alliance Partnership.

SASGO Members will now benefit from dual membership and gain access to IGCS Member benefits such as the Early Career Research & Publications Network,  the online member Education Portal (including the new Pathology Corner), AAGL’s SurgeryU video library, discounted registration for the IGCS Annual Global Meeting, and access to our online member community Social Link.

Greta Dreyer, who serves as SASGO President and as an IGCS Council Member, was instrumental in communicating with SASGO Council and Members and sharing feedback with IGCS leadership to discuss challenges and opportunities to collaborate and share resources to improve treatment of women affected by gynecologic cancers in South Africa.

SASGO was founded in 2006 to promote excellence in gynaecologic cancer care through training, research, and quality of care. They also advocate on behalf of women in South Africa by liaising with concerned governmental and non-governmental groupings, institutes for training and examination, authorities, and related advisory and research groups.

South Africa, with a population of 55 million, is a multiethnic society encompassing a wide variety of cultures and religions with 11 official languages. According to the International Agency for Research on Cancer, breast and cervical cancer are the most prevalent cancers affecting women in South Africa with cervical cancer being number one cause of cancer-related deaths. Vulvar, uterine, and ovarian cancer are also among the top eight most prevalent cancers in the country.

We look forward to our partnership with SASGO, to serve the gynecologic cancer professionals in the region, unite them with our global community, and to find ways to achieve our common goals to fight gynecologic cancers through training, education and public awareness.

IJGC Editorial Fellows

We are pleased to congratulate the five young gynecologic oncologists selected to serve as Editorial Fellows for the International Journal of Gynecological Cancer (IJGC). The fellows are IGCS Members and a part of the IGCS Early Career Research & Publications Network.

Geetu Bandoria
Indian Armed Forces
India
Arthur Hsu
National Taiwan University Hospital Hsin-Chu Branch
Taiwan
Sadie Jones
Cardiff University
Wales, UK
Navya Nair
Louisiana State University
USA
Florencia Noll
Hospital Italiano de Buenos Aires
Argentina

The IJGC Editorial Fellowship is a four-month appointment that matches the fellows with the Editor in Chief, Dr. Pedro Ramirez to gain experience in peer review processing, proposal/manuscript development, medical journal production, working with authors, editorial board management, and implementing a strategic vision plan.

Dr. Pedro Ramirez said, “We are very pleased to announce the selection of this outstanding group of gynecologic oncologists as the new Editorial Fellows of the International Journal of Gynecological Cancer. Looking forward to a very productive collaboration and to their innovative input in continuing to improve the quality of our journal. Congratulations!!”

The fellows will work on special projects based on personal areas of interest and the needs of the journal to further develop their skills to further their own research careers and effect change in the quality of medical research.

We are so pleased that IJGC has provided this fantastic opportunity for professional development to these members of the IGCS Early Career Research & Publications Network. The IGCS Early Career Network is open to all IGCS members within the first five years of completion of fellowship.

Sincerely,

Robert Coleman, MD
IGCS President Elect and Chair of the Early Career Research & Publications Network

Mary Eiken, MS
IGCS Chief Executive Officer

 

What the fellows have to say:

“Thrilled to be selected as IJGC Editorial fellow. Hoping to learn from the entire editorial team, and becoming a better authors & reviewer”
– Geetu Bhandoria

“It’s truly my honor to have such a great opportunity to serve as an editorial fellow for IJGC. I am thrilled about the activities in the fellowship and can’t wait to be connecting with doctors all around the globe. I am indebted to IGCS/IJGC as you provide exceptional learning programs for enthusiasts in the field. A shout out to the IGCS Early Career Research & Publications Network who are starting to fight gynecological cancer, together!”
– Arthur Hsu

“I am thrilled for this opportunity to gain an in depth understanding of the editorial process and be able to do so while collaborating with colleagues across the globe! Through this fellowship, I aspire to become a better scientific writer and more effectively mentor my trainees on the manuscript writing process. I look forward to using these new skills to help elevate the quality of gynecologic cancer research we publish and the oncologic care we provide here at Louisiana State University-New Orleans.”
-Navya Nair

“The possibility of participating in this program represents a wonderful challenge. This will be a great opportunity for me to get involved with the IGCS and learn about the development of protocols, manuscripts writing, reviewing processes, and also to encourage worldwide collaborative research projects. The IGCS Early Career Network allows me to continuously grow in my professional development and improve my patient’s care. I am grateful to have this unique opportunity!”
-Florencia Noll

IGCS 2020 xDigital Meeting

June 1, 2020

Dear Colleague,

Like many of you, the International Gynecologic Cancer Society (IGCS) leadership has been monitoring COVID-19 over the last several months. We are aware of the challenging times and our primary concern is for the health and safety of those of you in the global gynecologic oncology community who attend the IGCS Annual Global Meeting and of course the patients you serve.

The IGCS Council has decided that the best course of action is to postpone our previous plans to gather in Rome and to conduct the 2020 IGCS Annual Global Meeting as a fully digital meeting.

We are now re-launching the IGCS Annual Global Meeting, scheduled for September 10-13, 2020 utilizing innovative “xDigital” technology designed by our new service provider, iCrossing.

During this challenging time, we believe it is important now more than ever for health care professionals, survivors, and caregivers as well as our industry colleagues to come together on our new digital platform. We are committed to provide our members and delegates around the world with targeted educational programming, the latest scientific research in gynecologic cancers, and interactive networking opportunities. We have put a lot of thought and consideration into re-engineering IGCS 2020 with xDigital technology and are proud to bring you an enhanced experience that you can join from the comfort of your home or office.

Contributions of speakers, authors, and the work of the Scientific Program Committee will be realized in the xDigital environment, and abstracts will be published in the digital congress portal as well as the International Journal of Gynecological Cancer. We are committed to delivering industry symposia at our continued high level of engagement and to finding innovative and unique ways for participants to engage with industry and IGCS in our digital exhibition hall.

Please visit the meeting website to learn more about the IGCS xDigital Annual Global Meeting. Registration and abstract submission are now open! Abstracts will be accepted through July 15th.

www.igcsmeeting.com

It is important for the gynecologic oncology community to come together and continue to share research, experiences, and ideas and gather inspiration for the sake of caring for patients with gynecologic malignancies. IGCS has always served to unite the globe in the fight against gynecologic cancers and while we cannot be together face to face this year, we can still gather in this new way to present and hear the latest scientific research, discuss and share ideas, and connect with old friends while having the opportunity to meet new ones.

Prof. Roberto Angioli
IGCS President

Profs. Rainer Kimmig & Thomas Herzog
Co-Chairs, IGCS 2020 Scientific Program Committee

Learn more about the innovative xDigital platform by viewing this video demo.